Alvotech (ALVO) FCF Payout Ratio Growth (1y) (2023 - 2026)
Alvotech (ALVO) FCF Payout Ratio Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.00 Bn | 43.04 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.78 Bn | 30.10 Bn | 1.05 Bn | -14.68% |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.92 Bn | 5.10 Bn | -49.97% |
| 5 | United Therapeutics | 22.21 Bn | 19.54 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | -49.30% |
| 7 | Neurocrine Biosciences | 15.60 Bn | 15.21 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alvotech | 1.23 Bn | 1.23 Bn | 5.09 Mn | -211.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -471.14% |
| Sep 30, 2025 | 227.40% |
| Jun 30, 2025 | 44.22% |
| Mar 31, 2025 | 204.56% |
| Dec 31, 2024 | -601.94% |
| Jun 30, 2024 | -32.95% |
| Mar 31, 2024 | 41.33% |
| Dec 31, 2023 | 83.47% |